Building a leading one-stop ambulatory cancer center

SIAMH has successfully registered the offer document, launched an IPO and raised US$19.5 million.

SIAMH is a one-stop outpatient diagnostics and treatment center for cancer, neurogenerative and cardiovascular diseases in Singapore.

Oaklins’ team in Singapore acted as sponsor, issue manager, underwriter and placement agent in this transaction.